Tapi Nl Bv, based in Israel, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is GLYCEROL PHENYLBUTYRATE, with a corresponding US DMF Number 37042.
Remarkably, this DMF maintains an Active status since its submission on June 27, 2022, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 08, 2022, and payment made on May 24, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II